Matisse, Pharmaceuticals Matisse Pharmaceuticals meets primary objectives in study with M6229 in critically ill sepsis patients 07.08.2025 - 18:08:00 Matisse Pharmaceuticals B.V. Netherlands United Kingdom United States of America View original content:https://www.prnewswire.co.uk/news-releases/matisse-pharmaceuticals-meets-primary-objectives-in-study-with-m6229-in-critically-ill-sepsis-patients-302046879.html
